Zensar Technologies (504067) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
26 May, 2026Financial performance and growth
Achieved $643.7M in total revenue and maintained a net cash position of $319.5M in FY26.
Order book reached $912.7M, with 36% influenced by AI initiatives.
Gross margin improved by 220 bps YoY to 31.9%, and net profit margin stood at 13.5%.
EBITDA margin was 16.0%, up 50 bps YoY.
Dividend payout was 44% of EPS, with ₹15 per share declared for FY26.
Strategic focus and AI transformation
Focused on transforming into an AI-native organization, embedding AI across platforms, services, and operations.
Launched ZenseAI, a modular agentic AI platform, and developed domain-specific AI solutions for BFSI, insurance, healthcare, and manufacturing.
Over 85% of workforce is AI-certified, with innovation driven by hackathons and partnerships.
Strengthened alliances with major technology partners and expanded co-innovation initiatives.
Enhanced verticalization and service line capabilities to win and execute large deals.
Market trends and industry context
AI adoption is accelerating, but challenges remain in data governance and ROI.
IT sector faces margin pressure from higher costs, client budget cuts, and offshore expansion.
NASSCOM revised industry growth projections to $350B by 2030, with low single-digit growth rates.
GCCs are proliferating, impacting traditional IT firms' market share.
Nifty IT Index declined 25% in 2026, with firms heavily reliant on US revenues most affected.
Latest events from Zensar Technologies
- Q1 FY27 revenue reached $159.5M, BFSI led growth, margins dipped, and order book surged.504067
Q1 26/27 - Record order book and profit growth in FY26, with final dividend of ₹12.60 per share recommended.504067
Q4 25/26 - Q3 FY26 saw revenue and margin growth, strong order book, and continued AI-driven investments.504067
Q3 25/26 - Q2 revenue up 4.2% YoY to $162.8M, with margin gains, AI momentum, and TMT headwinds.504067
Q2 25/26 - Record order book, stable margins, and strong BFSI/healthcare growth; BridgeView acquired.504067
Q2 24/25 - Q3 FY25 revenue up 8.6% YoY to $157.0M, with 15.6% EBITDA margin and record order book.504067
Q3 24/25 - Q4 FY25 saw 6.3% YoY revenue growth, higher PAT margin, strong order book, and increased dividends.504067
Q4 24/25 - Q1 FY26 revenue up 4.9% YoY to $162M, with strong AI and digital/cloud growth but margin pressures.504067
Q1 25/26